Level Biotechnology (ROCO:3118) Accounts Payable & Accrued Expense : NT$105.2 Mil (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Level Biotechnology Accounts Payable & Accrued Expense?

Level Biotechnology's quarterly accounts payable & accrued expense increased from Sep. 2023 (NT$80.8 Mil) to Dec. 2023 (NT$94.3 Mil) and increased from Dec. 2023 (NT$94.3 Mil) to Mar. 2024 (NT$105.2 Mil).

Level Biotechnology's annual accounts payable & accrued expense increased from Dec. 2021 (NT$94.0 Mil) to Dec. 2022 (NT$100.1 Mil) but then declined from Dec. 2022 (NT$100.1 Mil) to Dec. 2023 (NT$94.3 Mil).

Level Biotechnology Accounts Payable & Accrued Expense Historical Data

The historical data trend for Level Biotechnology's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Biotechnology Accounts Payable & Accrued Expense Chart

Level Biotechnology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

121.62

111.74

94.00

100.10

94.31

Level Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															88.02	137.62	80.78	94.31	105.21

Level Biotechnology Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Level Biotechnology (ROCO:3118) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Level Biotechnology Inc (ROCO:3118) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.80, Lane 169, Kangning Street, Hsi-Chih, New Taipei, TWN, 221

Website

http://www.level.com.tw

Level Biotechnology Inc is a Taiwan based company engages in the provision of biotechnological services. It offers cell culture, immune protein, gene nucleic acids, and molecular biology, and instruments and equipment. It offers preclinical trial services in the areas of mammalian toxicology, genetic toxicology, pharmacology, biocompatibility, and model animal production.

Level Biotechnology (ROCO:3118) Headlines

No Headlines